Accelerated postoperative radiotherapy with weekly concomitant boost in patients with locally advanced head and neck cancer

Radiotherapy and Oncology

Volumn 70, Issue 2, 2004, Pages 183-188

  Zouhair, Abderrahim ^a   Azria, David ^a   Pasche, Philippe ^a   Stupp, Roger ^a   Chevalier, Julia ^a   Betz, Michael ^a   Mirimanoff, René O ^a   Ozsahin, Mahmut ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Accelerated radiotherapy; Head and neck cancer; Locally advanced; Postoperative

Indexed keywords

ADULT; ADVANCED CANCER; CANCER CLASSIFICATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CONFERENCE PAPER; CONFIDENCE INTERVAL; CONTROLLED STUDY; DYSPHAGIA; EDEMA; ERYTHEMA; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; MORBIDITY; MUCOSA INFLAMMATION; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROBABILITY; RADIATION DOSE; SURVIVAL RATE; SURVIVAL TIME; TOXICITY; WEIGHT REDUCTION; XEROSTOMIA;

AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CONFIDENCE INTERVALS; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; POSTOPERATIVE PERIOD; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 1542498669     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2003.11.007     Document Type: Conference Paper

References (37)

1. Amdur R.J., Parson J.T., Mendenhall W.M., Million R.R., Stringer S.P., Cassisi N.J. Postoperative irradiation for squamous cell carcinoma of the head and neck: an analysis of treatment results and complications. Int J Radiat Oncol Biol Phys. 16:1989;25-36.
2. Ang K. Altered fractionation in head and neck cancer. Semin Radiat Oncol. 8:1998;131-146.
3. Ang K.K., Trotti A., Brown B.W., et al. Randomized trial addressing risk features and time factors of surgery and radiotherapy in advanced head and neck cancer. Int J Radiat Oncol Biol Phys. 51:2001;571-578.
4. Awwad H.K., Khafagy Y., Barsoum M., et al. Accelerated versus conventional fractionation in the postoperative irradiation of locally advanced head and neck cancer: influence of tumor proliferation. Radiother Oncol. 25:1992;261-266.
5. Awwad H.K., Lotayef M., Shouman T., et al. Accelerated hyperfractionation (AHF) compared to conventional fractionation (CF) in the postoperative radiotherapy for locally advanced head and neck cancer: influence of proliferation. Br J Cancer. 86:2002;517-523.
6. Bernier J., Bentzen S. Altered fractionation and combined radio-chemotherapy approaches: pioneering new opportunities in head and neck oncology. Eur J Cancer. 39:2003;560-571.
7. Bernier J., Domenge C., Eschwege F., et al. Chemo-radiotherapy as compared to radiotherapy alone, significantly increases disease-free an overall survival in head and neck cancer patients after surgery: results of EORTC Phase III trial 22931. Int J Radiat Oncol Biol Phys. 51:(Suppl 1):2001;1.
8. Cooper J.S., Pajak T.F., Forastiere A.A., et al. Postoperative concurrent radiochemotherapy in high-risk SCCA of the head and neck: initial report of RTOG 9501/intergroup phase III trial. In: Proceedings of the Thirty-Eight Annual Meeting of the American Society of Clinical Oncology. 2002;Lippincott Williams & Wilkins, Orlando, FL. p. 226a.
9. Cox D.R. Regression models and life tables. J R Stat Soc. 34:1972;187-220.
10. Denham J.W., Peters L.J., Johansen J., et al. Do acute mucosal reactions lead to consequential late reactions in patients with head and neck cancer? Radiother Oncol. 52:1999;157-164.
11. Denis F., Garaud P., Manceau A., et al. Valeur pronostique du nombre de ganglions envahis après curage cervical pour carcinome de l'oropharynx et de la cavité buccale. Cancer/Radiother. 5:2001;12-22.
12. Dische S., Saunders M., Barrett A., Harvey A., Gibson D., Parmar M. A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer. Radiother Oncol. 44:1997;123-136.
13. Hliniak A., Gwiarzdowska B., Szutkowski Z., et al. A multicentre randomized/controlled trial of conventional versus modestly accelerated radiotherapy in the laryngeal cancer: influence of a 1 week shortening overall time. Radiother Oncol. 62:2002;1-10.
14. Horiot J.C., Bontemps P., Van den Bogaert W., et al. Accerelated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial. Radiother Oncol. 44:1997;111-121.
15. International Union Against Cancer (UICC). Sobin L.H., Wittekind C. TNM classification of malignant tumours. 6th ed:2002;19-47 Wiley-Liss, New York.
16. Jackson S.M., Weir L.M., Hay J.H., Tsang V.H., Durham J.S. A randomized trial of accelerated versus conventional radiotherapy in head and neck cancer. Radiother Oncol. 43:1997;36-39.
17. Kaplan E.L., Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481.
18. Lundahl R.E., Foote R.L., Bonner J.A., et al. Combined neck dissection and postoperative radiation therapy in the management of the high-risk neck: a matched-pair analysis. Int J Radiat Oncol Biol Phys. 3:1998;529-534.
19. Mamelle G., Pampurik J., Luboinski B., Lancar R., Lusinchi A., Bosq J. Lymph node prognostic factors in head and neck squamous cell carcinomas. Am J Surg. 168:1994;494-498.
20. Mirimanoff R.O., Wang C.C., Doppke K.P. Combined surgery and postoperative radiation therapy for advanced laryngeal and hypopharyngeal carcinomas. Int J Radiat Oncol Biol Phys. 11:1985;499-504.
21. Nguyen L.N., Ang K.K. Radiotherapy for cancer of the head and neck: altered fractionation regimens. Lancet Oncol. 11:2002;693-701.
22. Olsen K.D., Caruso M., Foote R.L., et al. Primary head and neck cancer: histopathologic predictors of recurrence after neck dissection in patients with lymph node involvement. Arch Otolaryngol Head Neck Surg. 120:1994;1370-1374.
23. Overgaard J., Hansen H.S., Specht L., et al. Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6&7 randomised controlled trial. Lancet. 362:2003;933-940.
24. Peters L.J., Goepfert H., Ang K., et al. Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial. Int J Radiat Oncol Biol Phys. 26:1993;3-11.
25. Peters L.J., Withers R. Applying radiobiological principles to combined modality treatment of head and neck cancer: the time factor. Int J Radiat Oncol Biol Phys. 39:1997;831-836.
26. Peto P., Pike M.C., Armitage P., et al. Design and analysis of randomised clinical trials requiring prolonged observation of each patients: part II. Br J Cancer. 35:1977;1-39.
27. Piquet M.A., Ozsahin M., Larpin I., et al. Early nutritional intervention in oropharyngeal cancer patients undergoing radiotherapy. Support Care Cancer. 10:2002;502-504.
28. Roland N.J., Caslin A.W., Nash J., Stell P.M. Value of grading squamous cell carcinoma of the head and neck. Head Neck. 14:1992;224-229.
29. Rudoltz M.S., Benammar M.S., Mohiuddin M. Does pathologic node status affect local control in patients with carcinoma of the head and neck treated with radical surgery and postoperative radiotherapy? Int J Radiat Oncol Biol Phys. 31:1995;503-508.
30. Sanguineti G., Corvo R., Vitale V., Lionetto R., Foppiana F. Postoperative radiotherapy for head and neck squamous cell carcinomas: feasibility of a biphasic accelerated treatment schedule. Int J Radiat Oncol Biol Phys. 36:1996;1147-1153.
31. Shah N., Saunders I., Dische S. A pilot study of postoperative CHART and CHARTWEL in head and neck cancer. Clin Oncol. 12:2000;392-396.
32. Skladowski K., Maciejewski J., Golen M., Pilecki B., Preorek W., Tarnawski R. Randomized clinical trial on 7-day continuous accelerated irradiation (CAIR) of head and neck cancer: report on 3-year tumour control and normal tissue toxicity. Radiother Oncol. 55:2000;93-102.
33. Smeele L.E., Leemans C.R., Langendijk J.A., et al. Positive surgical margins in neck dissection specimens in patients with head and neck squamous cell carcinoma and the effect of radiotherapy. Head Neck. 22:2000;559-563.
34. Trotti A., Klotch D., Endicott J., Ridley M., Cantor A. Postoperative accelerated radiotherapy in high risk squamous cell carcinoma of the head and neck: long-term results of a prospective trial. Head Neck. 20:1998;119-123.
35. Trotti A., Klotch D., Endicott J., Ridley M., Greenberg H.A. Prospective trial of accelerated radiotherapy in the postoperative treatment of high-risk squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 26:1993;13-21.
36. Tupschong L., Scott C.B., Blitzer P.H., et al. Randomized study of preoperative versus postoperative radiation therapy in advanced head and neck carcinoma: long-term follow-up of RTOG study 73-03. Int J Radiat Oncol Biol Phys. 20:1991;21-28.
37. Withers H.R., Taylor J.M.G., Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol. 27:1988;131-146.